Subacute toxicity and endocrine-disrupting effects of FeO, ZnO, and CeO nanoparticles on amphibian metamorphosis.

This study evaluated the potential toxic and endocrine-disrupting effects of sublethal concentrations of FeO, CeO and ZnO nanoparticles (NPs) on amphibian metamorphosis. Tadpoles were exposed to several NPs concentrations, reaching a maximum of 1000 µg/L, for up to 21 days according to the amphibian metamorphosis assay (AMA). Some standard morphological parameters, such as developmental stage (DS), hind limb length (HLL), snout-to-vent length (SVL), wet body weight (WBW), and as well as post-exposure lethality were recorded in exposed organisms on days 7 and 21 of the bioassay.

Haemophagocytic lymphohistiocytosis in a patient with left ventricular assist device.

Left ventricular assist devices provide circulatory support to heart failure patients while awaiting a suitable donor heart. However, with their increased duration of therapy, complications are seen frequently. Although coagulation disorders (bleeding and thrombosis) are the most common complications, infection is also a major complication associated with significant morbidity.

Morbidity and mortality risk among patients with screening-detected severe hypertension in the Malmö Preventive Project.

Objective: Screening of hypertension has been advocated for early detection and treatment. Severe hypertension (grade 3 hypertension) is a strong predictor for cardiovascular disease. This study aimed to evaluate not only the risk factors for developing severe hypertension, but also the prospective morbidity and mortality risk associated with severe hypertension in a population-based screening and intervention programme.

Monitoring treatment adherence in hypertension.

Hypertension is associated with high mortality and morbidity that will increase if hypertension is left untreated. Treatment adherence is crucial in blood pressure control, and monitoring patient adherence is essential to the successful management of hypertension, since nonadherence is associated with poor prognosis. There are both direct and indirect methods to monitor adherence.

Hypertension in women--pathophysiological and clinical aspects.

Hypertension is the most important risk factor, responsible for cardiovascular morbidity and mortality worldwide, both in men and women. Cardiovascular disorders in women are still underestimated, due to lower absolute risk calculations and the underdetection of classical risk factors. In recent years the differences in pathophysiology and the clinical presentation and treatment of cardiac diseases in women have become fields of interest and research.

7th meeting on hypertension and atherosclerosis.

The 7th Meeting on Hypertension and Atherosclerosis was organized in collaboration with the Society of Hypertension and Atherosclerosis and endorsed by the European Society of Hypertension. From basic sciences to clinical aspects, the congress covered the wide spectrum of cardiovascular health, providing a venue for the conversation of scientists from all around the world. At the end of the 5 days, participants had the opportunity discuss the main topics and updates on hypertension and atherosclerosis.

What we have learned from risk charts?

Evaluation of: Sehestedt T, Jeppesen J, Hansen TW et al.: Risk stratification with the risk chart from the European Society of Hypertension compared with SCORE in the general population. J.

[Unmet needs in hypertension].

Hypertension is considered one of the world's most important health problems. Approximately one billion people are affected in the world. Almost for 50 years, effective medical treatment in reducing blood pressure are among the tools of cardiovascular medical treatment.